$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

$ams Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000143774924010308 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$5.216M	$5.698M	$21.33M
YoY Change	5.91%	13.12%	8.0%
Cost Of Revenue	$3.073M	$2.882M	$11.98M
YoY Change	1.86%	4.16%	5.43%
Gross Profit	$2.143M	$2.816M	$9.344M
YoY Change	12.32%	24.05%	11.48%
Gross Profit Margin	41.09%	49.42%	43.82%
Selling, General & Admin	$1.879M	$1.760M	$7.022M
YoY Change	22.09%	23.94%	36.48%
% of Gross Profit	87.68%	62.5%	75.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.334M	$1.295M	$5.165M
YoY Change	-2.41%	5.63%	7.99%
% of Gross Profit	62.25%	45.99%	55.28%
Operating Expenses	$1.879M	$1.760M	$7.022M
YoY Change	22.09%	23.94%	36.48%
Operating Profit	-$85.00K	$1.056M	$2.322M
YoY Change	-186.73%	24.24%	-4.48%
Interest Expense	$349.0K	-$179.0K	-$686.0K
YoY Change	28.78%	-12.25%	-185.11%
% of Operating Profit		-16.95%	-29.54%
Other Income/Expense, Net
YoY Change
Pretax Income	$21.00K	$515.0K	$696.0K
YoY Change	-87.5%	-20.28%	-72.36%
Income Tax	-$44.00K	$338.0K	$431.0K
% Of Pretax Income	-209.52%	65.63%	61.93%
Net Earnings	$119.0K	$415.0K	$610.0K
YoY Change	-36.7%	68.7%	-54.07%
Net Earnings / Revenue	2.28%	7.28%	2.86%
Basic Earnings Per Share	$0.02		$0.10
Diluted Earnings Per Share	$0.02	$0.06	$0.10
COMMON SHARES
Basic Shares Outstanding	6.330M	6.300M	6.358M
Diluted Shares Outstanding	6.576M		6.393M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.79M	$13.69M	$13.69M
YoY Change	-2.22%	10.99%	10.99%
Cash & Equivalents	$12.79M	$13.69M	$13.69M
Short-Term Investments
Other Short-Term Assets	$1.588M	$1.919M	$1.919M
YoY Change	-7.41%	-15.09%	-15.09%
Inventory
Prepaid Expenses
Receivables	$6.429M	$4.343M	$4.343M
Other Receivables	$556.0K	$504.0K	$504.0K
Total Short-Term Assets	$21.37M	$20.46M	$20.46M
YoY Change	9.17%	9.26%	9.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$26.93M	$25.92M	$25.92M
YoY Change	19.46%	8.89%	8.89%
Goodwill	$1.265M	$1.265M
YoY Change	0.0%	0.0%
Intangibles	$78.00K	$78.00K
YoY Change	0.0%	0.0%
Long-Term Investments
YoY Change
Other Assets	$482.0K	$443.0K	$443.0K
YoY Change	460.47%	409.2%	409.2%
Total Long-Term Assets	$28.76M	$27.71M	$27.71M
YoY Change	19.95%	9.8%	9.8%
TOTAL ASSETS
Total Short-Term Assets	$21.37M	$20.46M	$20.46M
Total Long-Term Assets	$28.76M	$27.71M	$27.71M
Total Assets	$50.12M	$48.16M	$48.16M
YoY Change	15.1%	9.57%	9.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$267.0K	$315.0K	$315.0K
YoY Change	5.12%	36.96%	36.96%
Accrued Expenses	$2.335M	$2.040M	$2.040M
YoY Change	5.23%	-20.65%	-20.65%
Deferred Revenue
YoY Change
Short-Term Debt	$2.400M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.710M	$4.584M	$4.584M
YoY Change	114.74%	263.23%	263.23%
Total Short-Term Liabilities	$10.78M	$10.78M	$10.78M
YoY Change	105.16%	108.29%	108.29%
LONG-TERM LIABILITIES
Long-Term Debt	$12.89M	$11.04M	$11.04M
YoY Change	12.17%	-9.54%	-9.54%
Other Long-Term Liabilities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$12.89M	$11.04M	$11.04M
YoY Change	12.17%	-9.54%	-10.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.78M	$10.78M	$10.78M
Total Long-Term Liabilities	$12.89M	$11.04M	$11.04M
Total Liabilities	$23.74M	$25.54M	$25.54M
YoY Change	33.92%	39.32%	14.36%
SHAREHOLDERS EQUITY
Retained Earnings	$3.748M	$3.629M
YoY Change	16.87%	20.21%
Common Stock	$19.09M	$19.00M
YoY Change	2.09%	2.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.84M	$22.62M	$22.62M
YoY Change
Total Liabilities & Shareholders Equity	$50.12M	$48.16M	$48.16M
YoY Change	15.1%	9.57%	9.57%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$119.0K	$415.0K	$610.0K
YoY Change	-36.7%	68.7%	-54.07%
Depreciation, Depletion And Amortization	$1.334M	$1.295M	$5.165M
YoY Change	-2.41%	5.63%	7.99%
Cash From Operating Activities	-$1.865M	-$3.062M	$5.718M
YoY Change	-205.91%	-291.14%	-20.97%
INVESTING ACTIVITIES
Capital Expenditures	$1.183M	$93.00K	$6.273M
YoY Change	466.03%	66.07%	1516.75%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.183M	-$93.00K	-$6.273M
YoY Change	466.03%	66.07%	1516.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net	$164.0K		$2.129M
YoY Change	-77.53%		4.77%
Cash From Financing Activities	$2.282M	2.310M	1.910M
YoY Change	-383.83%	-405.15%	-171.89%
NET CHANGE
Cash From Operating Activities	-$1.865M	-3.062M	5.718M
Cash From Investing Activities	-$1.183M	-93.00K	-6.273M
Cash From Financing Activities	$2.282M	2.310M	1.910M
Net Change In Cash	-$766.0K	-845.0K	1.355M
YoY Change	-202.41%	-207.1%	-67.66%
FREE CASH FLOW
Cash From Operating Activities	-$1.865M	-$3.062M	$5.718M
Capital Expenditures	$1.183M	$93.00K	$6.273M
Free Cash Flow	-$3.048M	-$3.155M	-$555.0K
YoY Change	-296.39%	-304.08%	-108.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	250000	usd
CY2022Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	120000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6300000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6300000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6184000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6184000
CY2023Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P10Y
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	57000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	1-08789
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-2918118
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	601 Montgomery
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94111-2619
CY2023	dei	City Area Code CityAreaCode	415
CY2023	dei	Local Phone Number LocalPhoneNumber	788-5300
CY2023	dei	Security12b Title Security12bTitle	Common Stock No Par Value
CY2023	dei	Trading Symbol TradingSymbol	AMS
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Public Float EntityPublicFloat	11205000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6330000
CY2023	dei	Auditor Firm AuditorFirmId	659
CY2023	dei	Auditor Name AuditorName	Moss Adams LLP
CY2023	dei	Auditor Location AuditorLocation	Seattle, WA United States
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13690000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12335000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	118000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	118000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4343000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3801000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	504000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	327000	usd
CY2023Q4	ams	Prepaid Maintenance Current PrepaidMaintenanceCurrent	1275000	usd
CY2022Q4	ams	Prepaid Maintenance Current PrepaidMaintenanceCurrent	1245000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	526000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	897000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	20456000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	18723000	usd
CY2023Q4	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	25844000	usd
CY2022Q4	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	23467000	usd
CY2023Q4	us-gaap	Land Land	19000	usd
CY2022Q4	us-gaap	Land Land	19000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1265000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1265000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	57000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	317000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	443000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	87000	usd
CY2023Q4	us-gaap	Assets Assets	48162000	usd
CY2022Q4	us-gaap	Assets Assets	43956000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	315000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	230000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	757000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	735000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1226000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1544000	usd
CY2023Q4	ams	Asset Retirement Obligation Related Party Current AssetRetirementObligationRelatedPartyCurrent	650000	usd
CY2022Q4	ams	Asset Retirement Obligation Related Party Current AssetRetirementObligationRelatedPartyCurrent	360000	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	1229000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	255000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	57000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	292000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2500000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2084000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1262000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10779000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5175000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	59000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11041000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12205000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	70000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	63000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	822000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	21883000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18331000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	10763000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10763000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8232000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7843000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3629000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3019000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	22624000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21625000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	3655000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	4000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26279000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25625000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48162000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43956000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21325000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19746000	usd
CY2023	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	2032000	usd
CY2022	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	1878000	usd
CY2023	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	5073000	usd
CY2022	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	4726000	usd
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	4025000	usd
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	3666000	usd
CY2023	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	851000	usd
CY2022	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	1094000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	11981000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	11364000	usd
CY2023	us-gaap	Gross Profit GrossProfit	9344000	usd
CY2022	us-gaap	Gross Profit GrossProfit	8382000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7022000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5145000	usd
CY2023	us-gaap	Interest Expense InterestExpense	1112000	usd
CY2022	us-gaap	Interest Expense InterestExpense	806000	usd
CY2023	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	940000	usd
CY2022	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	0	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	270000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	2431000	usd
CY2023	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	426000	usd
CY2022	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	87000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	696000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2518000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	431000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	963000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	265000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1555000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-345000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	227000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	610000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1328000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.1
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.1
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6358000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6297000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6393000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6303000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24239000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	399000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	573000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1555000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25625000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	389000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	265000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26279000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	265000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	1555000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5165000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4783000	usd
CY2023	ams	Noncash Lease Expense NoncashLeaseExpense	-34000	usd
CY2022	ams	Noncash Lease Expense NoncashLeaseExpense	-40000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	46000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	84000	usd
CY2023	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	940000	usd
CY2022	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-759000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	344000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	389000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	399000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	719000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-696000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-21000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	111000	usd
CY2023	ams	Increase Decrease In Asset Retirement Obligations Related Party IncreaseDecreaseInAssetRetirementObligationsRelatedParty	0	usd
CY2022	ams	Increase Decrease In Asset Retirement Obligations Related Party IncreaseDecreaseInAssetRetirementObligationsRelatedParty	-397000	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-491000	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-845000	usd
CY2023	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	-79000	usd
CY2022	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	608000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	974000	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	159000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5718000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7235000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6273000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	388000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6273000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-388000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2129000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2032000	usd
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	1400000	usd
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	-0	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1750000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	3900000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	-0	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	573000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	9000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	9000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	202000	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	48000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1910000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2657000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1355000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4190000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12453000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8263000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13808000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12453000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1066000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	722000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	297000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	169000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1955000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13690000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12335000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	118000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	118000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13808000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12453000	usd
CY2023Q4	ams	Number Of Medical Centers NumberOfMedicalCenters	12	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Use of estimates in the preparation of financial statements</b> – In preparing the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates reflected in the Company’s consolidated financial statements include the estimated useful lives of property and equipment and its salvage values, revenues and costs of sales for revenue sharing customers. Actual results could differ from those estimates.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p>
CY2023	us-gaap	Advertising Expense AdvertisingExpense	165000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	233000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Business and credit risk</b> – The Company maintains its cash balances, which exceed federally insured limits, in financial institutions. The Company believes it is <em style="font: inherit;">not</em> exposed to any significant credit risk on cash and cash equivalents. The Company monitors the financial condition of the financial institutions it uses on a regular basis.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">All of the Company’s revenue was provided by 15 locations or <em style="font: inherit;">1</em> PBRT unit and <em style="font: inherit;">14</em> Gamma Knife units in each of <em style="font: inherit;">2023</em> and <em style="font: inherit;">2022</em>. One location accounted for approximately 48% and 45% of the Company’s total revenue in <em style="font: inherit;">2023</em> and <em style="font: inherit;">2022</em>, respectively. At <em style="font: inherit;"> December 31, 2023</em>, two locations each individually accounted for 30% and 31% of total accounts receivable, respectively. At <em style="font: inherit;"> December 31, 2022</em>, four locations each individually accounted for 12%, 14%, 16% and 22% of total accounts receivable, respectively. The Company performs credit evaluations of its customers and generally does <em style="font: inherit;">not</em> require collateral. The Company has <em style="font: inherit;">not</em> experienced significant losses related to receivables from individual customers or groups of customers in any particular geographic area.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">All of the Company’s radiosurgery devices have been purchased through Elekta, to date. However, there are other manufacturers that also make radiosurgery devices.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p>
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-940000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-0	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	290000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	650000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	610000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1328000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6358000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6297000
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	35000
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	6000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6393000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6303000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.1
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.1
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21325000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19746000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5165000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4783000	usd
CY2023	us-gaap	Interest Expense InterestExpense	1112000	usd
CY2022	us-gaap	Interest Expense InterestExpense	806000	usd
CY2023	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	458000	usd
CY2022	us-gaap	Interest Income Interest Earning Asset InterestIncomeInterestEarningAsset	103000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	431000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	963000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	610000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1328000	usd
CY2023Q4	us-gaap	Assets Assets	48162000	usd
CY2022Q4	us-gaap	Assets Assets	43956000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	650000	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<b>Reclassifications</b> - Certain comparative balances as of and for the year ended have been reclassified to make them consistent with the current year presentation.
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	81227000	usd
CY2022Q4	ams	Property Plant And Equipment Gross Excluding Land PropertyPlantAndEquipmentGrossExcludingLand	74237000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	55383000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50770000	usd
CY2023Q4	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	25844000	usd
CY2022Q4	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	23467000	usd
CY2023	us-gaap	Depreciation Depreciation	5165000	usd
CY2022	us-gaap	Depreciation Depreciation	4783000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	58000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	58000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	57000	usd
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-940000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-0	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	0	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	591000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	472000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	92000	usd
CY2023Q4	ams	Accrued Operating Costs Current AccruedOperatingCostsCurrent	450000	usd
CY2022Q4	ams	Accrued Operating Costs Current AccruedOperatingCostsCurrent	539000	usd
CY2023Q4	ams	Accrued Liabilites Other Current AccruedLiabilitesOtherCurrent	304000	usd
CY2022Q4	ams	Accrued Liabilites Other Current AccruedLiabilitesOtherCurrent	322000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1226000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1544000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	46000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	84000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	164000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	198000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	164000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2157000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2907000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7732000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	493000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	13289000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	57000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	302000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	406000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	129000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	174000	usd
CY2023	us-gaap	Lease Cost LeaseCost	173000	usd
CY2022	us-gaap	Lease Cost LeaseCost	232000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	302000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	406000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M9D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0465	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0565	pure
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	234000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	290000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	666000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2350000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	30000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	168000	usd
CY2023	ams	Income Loss From Continuing Operations Before Income Taxes After Income Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesAfterIncomeAttributableToNoncontrollingInterest	696000	usd
CY2022	ams	Income Loss From Continuing Operations Before Income Taxes After Income Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesAfterIncomeAttributableToNoncontrollingInterest	2518000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	431000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	963000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	940000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	355000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	115000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	60000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	135000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	204000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1190000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	619000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-672000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	290000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-77000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	48000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-10000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	6000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-759000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	344000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	431000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	963000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	323000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	708000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	409000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	493000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	12000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	54000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	744000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1255000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	155000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	139000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	438000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	167000	usd
CY2023Q4	ams	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	12000	usd
CY2022Q4	ams	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	61000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	4000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	3000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	140000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	114000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	646000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	646000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1395000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1130000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	714000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	697000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	681000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	433000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	63000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	822000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	218000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	477000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	12000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	100000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	38000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	7000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	0	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	6000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-25000	usd
CY2023	ams	Effective Income Tax Rate Reconciliation Return To Provision Trueup Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueupAmount	18000	usd
CY2022	ams	Effective Income Tax Rate Reconciliation Return To Provision Trueup Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionTrueupAmount	52000	usd
CY2023	ams	Effective Income Tax Rate Reconciliation Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount	9000	usd
CY2022	ams	Effective Income Tax Rate Reconciliation Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount	-17000	usd
CY2023	ams	Effective Income Tax Rate Reconciliation Amt Tax Payable Adjustments Amount EffectiveIncomeTaxRateReconciliationAmtTaxPayableAdjustmentsAmount	0	usd
CY2022	ams	Effective Income Tax Rate Reconciliation Amt Tax Payable Adjustments Amount EffectiveIncomeTaxRateReconciliationAmtTaxPayableAdjustmentsAmount	208000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	17000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	106000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	168000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	431000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	963000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	17000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	287000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	278000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	295000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	9000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	17000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	287000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	278000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	58000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	116000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	389000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	67000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.72
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M29D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.72
CY2022	ams	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P7Y
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.29
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	18000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.64
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	95000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.76
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M29D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	25000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	70000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.89
CY2023	ams	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P7Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	19000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.69
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	146000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.83
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M8D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	38000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.79
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	31000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.84
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M17D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.89
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.49
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4000
CY2022	ams	Options Issued During Period Cashless Stock Options Exercised OptionsIssuedDuringPeriodCashlessStockOptionsExercised	3000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000	usd
CY2022	ams	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period Using Cash SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodUsingCash	2000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2023	ams	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0	pure
CY2022	ams	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.036	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.033	pure
CY2023Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1000000
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	72000
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04	pure
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	43000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	17000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	47000	usd

Files In Submission

Name	View Source	Status
0001437749-24-010308-index-headers.html	Edgar Link	pending
0001437749-24-010308-index.html	Edgar Link	pending
0001437749-24-010308.txt	Edgar Link	pending
0001437749-24-010308-xbrl.zip	Edgar Link	pending
ams-20231231.xsd	Edgar Link	pending
asha20231231_10k.htm	Edgar Link	pending
ex_584852.htm	Edgar Link	pending
ex_584853.htm	Edgar Link	pending
ex_584854.htm	Edgar Link	pending
ex_584855.htm	Edgar Link	pending
ex_584856.htm	Edgar Link	pending
ex_643778.htm	Edgar Link	pending
ex_643783.htm	Edgar Link	pending
ams-20231231_cal.xml	Edgar Link	unprocessable
ams-20231231_def.xml	Edgar Link	unprocessable
ams-20231231_lab.xml	Edgar Link	unprocessable
ams-20231231_pre.xml	Edgar Link	unprocessable
asha20231231_10k_htm.xml	Edgar Link	completed
ex_643794.htm	Edgar Link	pending
ex_643794img002.jpg	Edgar Link	pending
ex_643794img003.jpg	Edgar Link	pending
ex_643795.htm	Edgar Link	pending
ex_643819.htm	Edgar Link	pending
ex_643820.htm	Edgar Link	pending
ex_646059.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2024 Q1 Form 10-K Financial Statement

#000143774924010308 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2024 Q1 Form 10-K Financial Statement

#000143774924010308 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams